Moreover, Gaiser et al. [24] previously evaluated CD200 expression by immunohistochemistry in 53 primary tumors and 35 MCC metastases (local recurrence, lymph node metastases, in-transit metastases, and distant metastases). The gene discussed is CD200; the disease is Merkel cell skin cancer.